Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Gains from Investment Securities (2016 - 2025)

CorMedix (CRMD) has disclosed Gains from Investment Securities for 12 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 626.83% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.0 million through Dec 2025, down 30.47% year-over-year, with the annual reading at $1.7 million for FY2025, 20.44% down from the prior year.
  • Gains from Investment Securities hit $2.0 million in Q4 2025 for CorMedix, down from $2.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $25.4 million in Q1 2023 to a low of -$373615.0 in Q4 2024.
  • Historically, Gains from Investment Securities has averaged $3.2 million across 5 years, with a median of $1.4 million in 2021.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 4725.35% in 2021 and later plummeted 98.56% in 2024.
  • Year by year, Gains from Investment Securities stood at $6.5 million in 2021, then skyrocketed by 34.96% to $8.8 million in 2022, then plummeted by 78.33% to $1.9 million in 2023, then tumbled by 119.65% to -$373615.0 in 2024, then soared by 626.83% to $2.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CRMD at $2.0 million in Q4 2025, $2.1 million in Q3 2025, and $1.9 million in Q2 2025.